45 related articles for article (PubMed ID: 38641904)
1. Prognostic value of growth differentiation factor-15 in heart failure among whole ejection fraction phenotypes.
Lyu L; Xu J; Xv C; Xiao H; Liu Z; He Y; Gao W; Hao B; Liu H
ESC Heart Fail; 2024 Apr; ():. PubMed ID: 38641904
[TBL] [Abstract][Full Text] [Related]
2. S
Sun J; Xie Z; Ye M; Xu H; Dong Y; Liu C; Zhu W
ESC Heart Fail; 2024 Jun; 11(3):1422-1434. PubMed ID: 38327133
[TBL] [Abstract][Full Text] [Related]
3. Prognosis and Treatment Strategies for Atrial Fibrillation in Heart Failure with Mildly Reduced Ejection Fraction.
Schupp T; Schmitt A; Reinhardt M; Abel N; Lau F; Abumayyaleh M; Dudda J; Weidner K; Ayoub M; Akin M; Müller J; Akin I; Behnes M
Eur J Prev Cardiol; 2024 Jun; ():. PubMed ID: 38825871
[TBL] [Abstract][Full Text] [Related]
4. Change in left atrial function and volume predicts incident heart failure with preserved and reduced ejection fraction: Multi-Ethnic Study of Atherosclerosis.
Lim DJ; Varadarajan V; Quinaglia T; Pezel T; Wu C; Noda C; Heckbert SR; Bluemke D; Ambale-Venkatesh B; Lima JAC
Eur Heart J Cardiovasc Imaging; 2024 Jun; ():. PubMed ID: 38885142
[TBL] [Abstract][Full Text] [Related]
5. Predictive Value of the Hb/RDW Ratio for the Risk of All-Cause Death in Patients with Heart Failure with Different Ejection Fractions.
Zhou J; Ma W; Wan Y; Zhou Y; Wan W; Gu W; Li H; Xu C; Chen L
Cardiology; 2024; 149(3):237-247. PubMed ID: 38262371
[TBL] [Abstract][Full Text] [Related]
6. Titration of Medications After Acute Heart Failure Is Safe, Tolerated, and Effective Regardless of Risk.
Ambrosy AP; Chang AJ; Davison B; Voors A; Cohen-Solal A; Damasceno A; Kimmoun A; Lam CSP; Edwards C; Tomasoni D; Gayat E; Filippatos G; Saidu H; Biegus J; Celutkiene J; Ter Maaten JM; Čerlinskaitė-Bajorė K; Sliwa K; Takagi K; Metra M; Novosadova M; Barros M; Adamo M; Pagnesi M; Arrigo M; Chioncel O; Diaz R; Pang PS; Ponikowski P; Cotter G; Mebazaa A
JACC Heart Fail; 2024 May; ():. PubMed ID: 38739123
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic value of an ejection fraction adjusted for myocardial remodeling.
Chan WX; Kaura A; Mulla A; Papadimitriou D; Glampson B; Mayer E; Shah ASV; Mayet J; Yap CH
Front Cardiovasc Med; 2024; 11():1349338. PubMed ID: 38798923
[TBL] [Abstract][Full Text] [Related]
8. Relationship between serum uric acid levels and uric acid lowering therapy with the prognosis of patients with heart failure with preserved ejection fraction: a meta-analysis.
Li L; Chang Y; Li F; Yin Y
Front Cardiovasc Med; 2024; 11():1403242. PubMed ID: 38938653
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and prognostic value of cardiac magnetic resonance strain analysis in patients with different phenotypes of heart failure.
Zhao B; Zhang S; Chen L; Xu K; Hou Y; Han S
Front Cardiovasc Med; 2024; 11():1366702. PubMed ID: 38826817
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and prognosis of aortic valve diseases in patients hospitalized with heart failure with mildly reduced ejection fraction.
Schupp T; Abel N; Schmidberger M; Höpfner MK; Schmitt A; Reinhardt M; Forner J; Lau F; Akin M; Rusnak J; Akin I; Behnes M
Eur J Heart Fail; 2024 Jun; ():. PubMed ID: 38896059
[TBL] [Abstract][Full Text] [Related]
11. Association and Prognostic Value of Multidomain Frailty Defined by Cumulative Deficit and Phenotype Models in Patients With Heart Failure.
Fujimoto Y; Matsue Y; Maeda D; Kagiyama N; Sunayama T; Dotare T; Jujo K; Saito K; Kamiya K; Saito H; Ogasahara Y; Maekawa E; Konishi M; Kitai T; Iwata K; Wada H; Hiki M; Kasai T; Nagamatsu H; Ozawa T; Izawa K; Yamamoto S; Aizawa N; Wakaume K; Oka K; Momomura SI; Minamino T
Can J Cardiol; 2024 Apr; 40(4):677-684. PubMed ID: 38007218
[TBL] [Abstract][Full Text] [Related]
12. Serum metabolomics improves risk stratification for incident heart failure.
Oexner RR; Ahn H; Theofilatos K; Shah RA; Schmitt R; Chowienczyk P; Zoccarato A; Shah AM
Eur J Heart Fail; 2024 Apr; 26(4):829-840. PubMed ID: 38623713
[TBL] [Abstract][Full Text] [Related]
13. Integrated biomarker profiling for enhanced heart failure management: a comprehensive study on the application of chemiluminescence detection of GDF-15 and multi-index models.
Zhang J; Zhang J; Huang C; Wu T; Jin P
Lab Med; 2024 Jun; ():. PubMed ID: 38916138
[TBL] [Abstract][Full Text] [Related]
14. Initiation of Statins for Primary Prevention in Heart Failure With Preserved Ejection Fraction.
Orkaby AR; Goyal P; Charest B; Qazi S; Sheikh S; Shah S; Gaziano JM; Djousse L; Gagnon D; Joseph J
JACC Adv; 2024 Apr; 3(4):100869. PubMed ID: 38939680
[TBL] [Abstract][Full Text] [Related]
15. Advanced Heart Failure Characteristics and Outcomes in Women and Men.
Farooqui N; Killian JM; Smith J; Redfield MM; Dunlay SM
J Am Heart Assoc; 2024 Jun; ():e033374. PubMed ID: 38904243
[TBL] [Abstract][Full Text] [Related]
16. Association between preoperative phase angle and all-cause mortality after cardiovascular surgery: A retrospective cohort study.
Shibata K; Kameshima M; Adachi T; Kito H; Tanaka C; Sano T; Tanaka M; Suzuki Y; Tamaki M; Kitamura H
J Cachexia Sarcopenia Muscle; 2024 Jun; ():. PubMed ID: 38859616
[TBL] [Abstract][Full Text] [Related]
17. Associations Between Biomarkers of Myocardial Injury and Systemic Inflammation and Risk of Incident Ventricular Arrhythmia.
Sourour N; Riveland E; Næsgaard P; Kjekshus H; Larsen AI; Røsjø H; Omland T; Myhre PL
JACC Clin Electrophysiol; 2024 May; ():. PubMed ID: 38904572
[TBL] [Abstract][Full Text] [Related]
18. Circulating beta-hydroxybutyrate levels in advanced heart failure with reduced ejection fraction: Determinants and prognostic impact.
Monzo L; Kovar J; Borlaug BA; Benes J; Kotrc M; Kroupova K; Jabor A; Franekova J; Melenovsky V
Eur J Heart Fail; 2024 Jun; ():. PubMed ID: 38853653
[TBL] [Abstract][Full Text] [Related]
19. The Metabolic Vulnerability Index: A Novel Marker for Mortality Prediction in Heart Failure.
Conners KM; Shearer JJ; Joo J; Park H; Manemann SM; Remaley AT; Otvos JD; Connelly MA; Sampson M; Bielinski SJ; Wolska A; Turecamo S; Roger VL
JACC Heart Fail; 2024 Feb; 12(2):290-300. PubMed ID: 37480881
[TBL] [Abstract][Full Text] [Related]
20. Tailored Risk Stratification in Severe Mitral Regurgitation and Heart Failure Using Supervised Learning Techniques.
Heitzinger G; Spinka G; Prausmüller S; Pavo N; Dannenberg V; Donà C; Koschutnik M; Kammerlander A; Nitsche C; Arfsten H; Kastl S; Strunk G; Hülsmann M; Rosenhek R; Hengstenberg C; Bartko PE; Goliasch G
JACC Adv; 2022 Aug; 1(3):100063. PubMed ID: 38938405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
